PureHealth delivers strong H1 2025 results with AED 13.6bln in revenue and AED 1.03bln in net profit
As part of its continued evolution and transformation of acquired assets, PureHealth is streamlining its operating model built around two core verticals: Care and Cover. This structure brings together all Group businesses under each vertical, with 'Care' encompassing Hospitals, Procurement, Diagnostics, and Technology, while 'Cover' includes the Group's Insurance operations. The new model strengthens PureHealth's ability to deliver coordinated, value-driven services by aligning care delivery with insurance offerings to streamlining operations across all levels of the health ecosystem. Furthermore, as PureHealth is the only entity in the MENA region which has both healthcare and insurance services under one umbrella, this new streamlined approach gives more transparency and clarity for investors to understand the vertical performance of the group.
H.E. Kamal Al Maazmi, Chairman of PureHealth, said: 'PureHealth's strong performance in the first half of 2025 reflects the profound ambition driving our transformation, building a global, future-ready healthcare ecosystem that is both technologically advanced and deeply human. By aligning innovation with national priorities and international partnerships, we are not only expanding access to care, but we are also reshaping how health is delivered, experienced, and sustained.'
Shaista Asif, Group Chief Executive Officer at PureHealth, commented, 'We delivered solid growth in the first half of 2025 across both our Care and Cover verticals. Our entry into the Property & Casualty segment through Daman strengthens our ability to offer comprehensive, multi-line coverage. We continue to enhance our services through AI-powered solutions that make healthcare more intelligent and efficient. As we expand globally, our focus remains on synergies, transformation of the assets, and delivering better health outcomes within communities we operate.'
Financial & Operational Highlights Across Healthcare (Care) and Insurance (Cover) Verticals:
The Care Vertical was the largest contributor to revenue during the period, accounting for 72% of the Group's top-line at AED 9.8 billion in revenue, up 7% year-on-year in H1 2025. This growth witnessed across several segments, including Hospitals, Diagnostics, and Technology.
Performance in UAE and UK was driven by a 13% increase in outpatient volumes to 4.4 million visits, and a 7% rise in inpatient volumes to 108,000 visits across the Hospitals vertical. In the UAE, this growth was supported by expanded service offerings, increased specialist capacity, and growing demand across SEHA and SSMC networks. In the UK, Circle Health saw increased patient volumes and further strengthened its position through the successful bolt on acquisition of Fairfield Independent Hospital in the Merseyside. The acquisition will expand inpatient capacity and available medical staff, which will ultimately support Circle Health's continued growth in high-demand regions.
While Procurement revenue decreased 5% year-on-year to AED 2.6 billion in H1 2025, Rafed has continued expansion of its supplier network. Its recent appointed role as the exclusive distributor for the Abu Dhabi government's Unified Purchasing Programme, has since strengthened its position as a central enabler within the Group's healthcare delivery model. PureLab recorded a 19% year-on-year increase in total testing volume, reaching 16.9 million tests. This strong performance was largely fuelled by enhanced contributions from SEHA and the successful integration of the SSMC laboratory into the PureLab network.
The Technology Services reported exceptional growth, with revenue increasing 170% year-on-year to AED 367 million in H1-2025. This was driven by the continued expansion of PureCS, which deployed digital infrastructure and clinical technology solutions across the Group's entities. The Pura app surpassed 620,000 users during the period, while the Group's broader technology backbone is enabling predictive analytics, digital patient engagement, and AI-enhanced care delivery.
The Cover vertical revenue increased 14% year-on-year to AED 3.8 billion, supported by an 8% rise in Gross Written Premiums (GWP) to AED 4.9 billion in H1-2025. Growth was further fuelled by new business, driven by expansion into underpenetrated segments and geographies. Membership increased 6% year-on-year, reflecting the Group's compelling value proposition and strong customer retention.
PureHealth's balance sheet remains strong, with a Net Debt to EBITDA ratio of 1.4x, providing the Group with ample flexibility to pursue future M&A opportunities and invest in strategic organic growth initiatives across its global healthcare platform. PureHealth repaid AED 1.85 billion in bank debt ahead of its 2027 maturity and currently has no bank debt.
Strategic Developments
PureHealth acquired Hellenic Healthcare Group (HHG), the largest private healthcare provider in Greece and Cyprus, strengthening its presence in Europe and expanding its specialised care footprint. Closing of the transaction is subject to EU regulatory approvals.
Circle Health Group completed the acquisition of Fairfield Independent Hospital in Merseyside, adding inpatient capacity and expanding Circle's footprint in high-demand regions across the UK.
Daman has received approvals and licensing to enter the Property & Casualty insurance segment, marking its evolution into a comprehensive, multi-line insurer. It also launched new insurance offerings targeting underpenetrated segments and continued scaling digital claims and onboarding systems.
SEHA, through Sheikh Khalifa Medical City (SKMC), signed a strategic partnership with Cincinnati Children's Hospital, one of the top ranked US children's hospital, to advance paediatric clinical services, research, and training in Abu Dhabi.
Rafed was appointed as the exclusive distributor for the Unified Purchasing Programme under the Abu Dhabi government mandate, reinforcing its central position in the national procurement ecosystem.
OneHealth introduced TurnKey Solutions and Home Dialysis Project, supporting PureHealth's expansion toward home-based care and specialised treatment pathways.
Outlook
PureHealth is advancing its organic growth strategy through targeted investments in high-margin, complex medical capabilities, the development of clinical centres of excellence, and operational efficiency enhancements enabled by digital health and AI.
In parallel, PureHealth continues to expand its international footprint through focused M&A, including the acquisition of Hellenic Healthcare Group (HHG) in Greece and Cyprus. The Group's expansion strategy is supported by a balanced capital allocation framework, combining reinvestment in core strengths with a commitment to shareholder returns.
-Ends-
About PureHealth:
PureHealth is the largest healthcare group in the Middle East with an ecosystem that challenges lifespans and reimagines health spans. With 110+ hospitals, 316+ clinics, multiple diagnostic centres, health insurance solutions, pharmacies, health tech, procurement, investments and more, its groundbreaking innovations are at the forefront of healthcare as the company is on a mission to unlock time for humankind. By advancing the Science of Longevity, PureHealth is introducing the healthcare of the future from the United Arab Emirates to the rest of the world.
PureHealth's network comprises:
SEHA – One of the largest healthcare networks of hospitals and clinics in the UAE
SEHA CLINICS - Delivering comprehensive community-based healthcare services
Daman (The National Insurance Company) – The UAE's leading health insurer
The Medical Office – Overseeing Sheikh Khalifa Hospitals and healthcare facilities established under the initiatives of H.H. The President of the UAE
Rafed – The UAE's largest healthcare Group Purchasing Organisation
PureLab – Managing and operating the largest network of laboratories in the region
One Health – A network that provides end-to-end medical solutions to a base of over 300 healthcare service providers
The Life Corner – Abu Dhabi's first holistic pharmacy, serving the health and wellness establishment
Ardent Health Services – The fourth largest privately held acute care hospital operator in the US
Circle Health Group – The largest independent operators of hospitals in the UK
Hellenic Healthcare Group (HHG) - the largest private healthcare provider in Greece and Cyprus
PureCS - A leading cloud and technology services provider, specialising in IT management and consulting solutions, cybersecurity, cloud services and AI information systems
Sheikh Shakhbout Medical City (SSMC) – The UAE's largest healthcare complex, delivering integrated complex care
To learn more, please visit www.purehealth.ae
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
30 minutes ago
- Khaleej Times
'Scared to believe': UAE-based Bangladeshi tailor on winning Dh20 million in Big Ticket
The Dubai-based Bangladeshi tailor who won the Dh20-million jackpot in Big Ticket's latest draw on his first try said that his heart told him to buy a ticket. A UAE resident for over 18 years, Sabuj Miah Amir Hossain Dewan was in Abu Dhabi with a client when he decided to buy the ticket. 'I had gone for a work-related purpose with a client to Abu Dhabi when the thought popped into my head that I should buy a Big Ticket,' he told Khaleej Times. 'For many years, people I know have been buying, and they have often asked me to pitch in, but I always refused. This time, my heart just told me to buy a ticket.' One of the longest-running raffle draws in the region, Big Ticket, had announced several prizes for the summer. In July, another Bangladeshi, an electrician called Mohammed Naser Balal, won the Dh25 million grand prize. He was the one who picked the winning ticket entry this month. 'My heart was confident' After his work in Abu Dhabi, Sabuj asked a taxi driver how to buy a ticket. 'He pointed me in the direction of the store,' he said. 'Once I reached there, they said it would cost me Dh500. I hesitated and wondered if I should spend that much money on a raffle ticket. I could do so many other things with that money, but my heart was just adamant. It just kept telling me that I should buy.' After buying it on July 29, Sabuj said that every day he kept thinking of the ticket. 'I would be going about my day when suddenly I would remember the ticket and my heart would tell me that I would win,' he said. 'I kept telling myself that there was no chance I would win it the first time I bought it, but my heart was confident.' Five days later, his name was picked during the monthly Big Ticket raffle draw. First thing to do Even though he has received the official call, Sabuj still finds it difficult to believe that he has won. 'I will believe it when I get the cash in my hands,' he said. 'I have been getting a lot of calls from Bangladeshi media as well, but I have refused everything because somewhere, I am still a little scared to believe it.' He added that the first thing he wants to do is go to Makkah for the Islamic pilgrimage of Umrah. 'I had intended to do Umrah in January,' he said. 'Even when I was buying the ticket, I thought that even if I win, the first thing I want to do is perform a pilgrimage. Then I will decide what to do with the money.' Sabuj said his family, including his wife, two sons aged 10 and 3, mother and sister heard of the win through local Bangladeshi news channels and asked him about it. 'I told them that I took the ticket, but I am not sure if I won or not,' he said. 'If and when I get the money, I am sure God will show me the best way to spend it. I am entrusting all to the will of God.'
Khaleej Times
30 minutes ago
- Khaleej Times
Fertiglobe's revenue grows 14% to $566m in the second quarter
Fertiglobe, the world's largest seaborne exporter of urea and ammonia combined and the largest nitrogen fertiliser producer in the Middle East and North Africa region and Adnoc's low carbon ammonia platform, on Monday announced a revenue of $566 million, reflecting a 14 per cent year-on-year increase in the second quarter. Adjusted Ebitda grew 26 per cent to $176 million, with adjusted net profit attributable to shareholders stood at $12 million, representing a 68 per cent increase compared to Q2 2024. In the first half of 2025, Fertiglobe reported revenue of $1.26 billion, reflecting a 20 per cent increase year-on-year increase. Adjusted Ebitda for the period stood at $437 million, up 36 per cent year-on-year, while adjusted net profit attributable to shareholders stood at $85 million, representing an 18 per cent decline compared to the prior year, driven by a one-off forex gain in H1 2024. Ahmed El-Hoshy, CEO of Fertiglobe, commented: 'This quarter demonstrated Fertiglobe's growing operational resilience, with an adjusted Ebitda increase of 26 per cent Y-o-Y. Fertiglobe remains strategically placed to deliver robust performance and maintain operational continuity amid challenging conditions. We capitalised on the downtime in Egypt to perform critical maintenance activities, successfully extending the turnaround cycle, with maintenance capex expected towards the lower end of our previous guidance at $145 million. Notably, excluding external factors and turnarounds, our own-produced sales volumes for the second quarter of 2025 would have been up 4 per cent Y-o-Y, while H1 2025 own-produced sales volumes would have increased 7 per cent Y-o-Y. With the continued support of Adnoc, we remain confident in our strategic path to become a globally integrated nitrogen champion and creating long-term value for shareholders, while continuing to innovate and differentiate our solutions that support global food security and enable the energy transition.' The company proposed H1 2025 dividends of at least $100 million (4.4 fils per share), subject to board approval in September with payment in October. Including the $31 million worth of shares bought back in Q2 2025, Fertiglobe provides one of the highest total return metrics in the industry at the combined $131 million cash returns to shareholders for H1 2025. Additionally, Fertiglobe continues to execute on its announced 2.5 per cent share buyback programme, aimed at opportunistically capitalising on the stock's attractive valuation. As of 1 August 2025, Fertiglobe repurchased 55 million shares, representing 0.66 per cent of total outstanding shares. While Fertiglobe remains dedicated to advancing its low-carbon project portfolio, the Company recognises that the global low-carbon ammonia market remains in the early stages of development, with regulatory frameworks and demand signals continuing to evolve. As such, and in line with Fertiglobe's disciplined approach to capital deployment across its low-carbon ammonia project pipeline, Fertiglobe has taken the decision to rephase Project Rabdan1F, a 1 mtpa low-carbon ammonia project and associated auto-thermal reformer. This decision reflects the Company's prudent investment strategy and commitment to timing capital allocation effectively and is consistent with the broader objectives of the Grow 2030 Strategy, particularly its focus on disciplined low-carbon growth. In addition, Fertiglobe expects its recently announced proposed acquisition of the distribution assets of Wengfu Australia to play a key role in strengthening its downstream presence in high-netback markets, in line with its strategic focus on customer proximity. Wengfu Australia's distribution assets are also projected to enhance supply chain resilience and unlock long-term distribution synergies. The transaction is subject to regulatory approvals and is anticipated to close in H2 2025. As of 30 June 2025, Fertiglobe reported a net debt position of $909 million, implying a consolidated net debt to LTM adjusted Ebitda ratio of 1.0x. This strong financial position enables the Company to effectively balance growth investments and shareholder distributions, supported by robust free cash flow generation and a solid balance sheet. Fertiglobe is also set to realise $10 million of annual run rate interest savings in 2025, following credit rating upgrades by S&P, Fitch, and Moody's and driven by Adnoc's acquisition of a majority stake in Fertiglobe. These savings are further underpinned by the refinancing of our $300 million loan through the internal Adnoc bank and the recent repricing of a $1.1 billion term loan, supporting lower financing costs and contributing to earnings accretion in the quarter
The National
an hour ago
- The National
US tariffs to have 'close to zero' effect on Saudi Arabia, IMF says
The impact of tariffs imposed by the US on Saudi Arabia is expected to be 'close to zero', underpinning the kingdom's resilience against global economic shocks, the International Monetary Fund (IMF) has said. The kingdom, the Arab world's largest economy, was hit with a 10 per cent tariff in April – the lower tier of the levies set by US President Donald Trump. But with more than three quarters of Saudi exports to the US exempt from the levies, the direct impact will be 'quite limited', Amine Mati, the IMF's mission chief for the Middle East and Central Asia, told the media on Monday. 'If we were to look at trade with respect to the US, a lot of the trade is in oil products and non-oil exports are actually a very small portion,' he said. Saudi Arabia's non-oil exports to the US that could be subject to the tariffs are between 3 per cent and 4 per cent of total exports, which would mean 'the impact is almost none or close to zero', he added. 'There are some trade diversion gains … textiles and others could benefit, but [others such as] the chemical industries, because of the extra tariffs, would be losing.' Saudi Arabia's economy has shown 'strong resilience', defying global economic shocks amid the growth of its non-oil economy, tamed inflation and record-low unemployment, the IMF said in its annual assessment of the kingdom on Monday. The kingdom is expected to keep its non-oil growth above 3.5 per cent over the medium term, which mirrors the positive impacts led by its Vision 2030 economic programme, the Washington-based lender said. The IMF last week projected Saudi Arabia's economy to expand at a 3.6 per cent pace in 2025 and 3.9 per cent in 2026, supported by the continued phase-out of Opec production cuts. In 2024, non-oil real gross domestic product grew by 4.5 per cent, driven by retail, hospitality and construction, according to the agency. The country, the world's top-oil exporting nation, has enjoyed robust domestic demand spurred by government-led projects and the hosting of major international events, the IMF said. Consumer prices are expected to remain contained, it added. Saudi Arabia's banking sector remained resilient, with lenders' balance sheets staying robust underpinned by high capitalisation, profitability and non-performing loans at their lowest levels in nearly a decade, the IMF said. Services, industry and manufacturing also remain healthy. Unemployment among Saudi nationals also hit a record low, as the jobless rate among youth and women halved over four years, the lender added. The kingdom's current account deficit is projected to persist over the medium term at around 3 per cent, as 'investment-linked imports will continue as well as remittance outflows and despite some continued improvement in non-oil exports', Mr Mati said. Risks remain in the near term, however, including those from weaker oil demand due to global trade tensions, lower government spending and regional security risks that could dampen investor sentiment, he added. 'Of course, on the upside, if you have higher oil production or additional investment linked to Vision 2030 or accelerated implementation of reforms, that could also boost growth further,' Mr Mati said. Saudi Arabia is focusing on diversifying its economy away from oil with an emphasis on the development of sectors such as technology, property, tourism and infrastructure as part of Vision 2030. The kingdom is supporting the development of several industries spanning different sectors to generate employment and help its non-oil economy to grow. Technology will also play a vital role in Saudi Arabia's future economy, with the kingdom 'well-poised and well-placed' to take advantage of innovations such as artificial intelligence in terms of digitalisation among its ranks, Mr Mati said in response to a question from The National. While the IMF does not have a direct measure for technology, it acknowledged that 'this is an area of current work [for the kingdom], particularly because you need to look at it with respect to non-oil productivity more than total productivity', he said. Directors of the IMF's executive board said Saudi Arabia's strong economic performance merits a 'favourable' outlook, 'helped by appropriate macroeconomic policies, strong buffers and impressive reform momentum'. The directors agreed that a gradual fiscal consolidation is needed to achieve intergenerational equity, which could be achieved 'through broader tax policy reforms to increase non-oil revenue, wage bill containment, energy subsidy reform alongside better targeting social safety nets and streamlining of non-essential expenditures'.
